News on MAL from BioPortfolio.com http://www.BioPortfolio.com Consolidated MAL news from BioPortfolio.com Wed, 10 Feb 2010 03:20:08 GMT en FDA Approves Once-A-Day Lamictal XR as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizureshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025135&HITNO=0&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025135&THISHREF=http://c.moreover.com/click/here.pl%3fz2529449917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025135&HITNO=0&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025135&THISHREF=http://c.moreover.com/click/here.pl%3fz2529449917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Med-mal decision spurs reactionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017493&HITNO=1&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017493&THISHREF=http://c.moreover.com/click/here.pl%3fz2525169629%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017493&HITNO=1&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017493&THISHREF=http://c.moreover.com/click/here.pl%3fz2525169629%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Physician: Ill. decision on med-mal caps questionedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015715&HITNO=2&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015715&THISHREF=http://c.moreover.com/click/here.pl%3fz2524494699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015715&HITNO=2&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015715&THISHREF=http://c.moreover.com/click/here.pl%3fz2524494699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Physician: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001898&HITNO=3&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001898&THISHREF=http://c.moreover.com/click/here.pl%3fz2518619846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001898&HITNO=3&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001898&THISHREF=http://c.moreover.com/click/here.pl%3fz2518619846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: FDA Approves Once-A-Day Lamictal(R)XR(TM) As Add-On Epilepsy Therapy For Primary Generalized Tonic-Clonic Seizhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996418&HITNO=4&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996418&THISHREF=http://c.moreover.com/click/here.pl%3fz2516293379%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996418&HITNO=4&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996418&THISHREF=http://c.moreover.com/click/here.pl%3fz2516293379%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: FDA Approves GlaxoSmithKline (GSK)'s Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991884&HITNO=5&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991884&THISHREF=http://c.moreover.com/click/here.pl%3fz2513911008%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991884&HITNO=5&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991884&THISHREF=http://c.moreover.com/click/here.pl%3fz2513911008%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: GlaxoSmithKline's (GSK) Lamictal XR Approved by U.S. FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990641&HITNO=6&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990641&THISHREF=http://c.moreover.com/click/here.pl%3fz2513393885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990641&HITNO=6&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990641&THISHREF=http://c.moreover.com/click/here.pl%3fz2513393885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989191&HITNO=7&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989191&THISHREF=http://c.moreover.com/click/here.pl%3fz2512062229%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989191&HITNO=7&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989191&THISHREF=http://c.moreover.com/click/here.pl%3fz2512062229%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBenzinga.com: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988618&HITNO=8&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988618&THISHREF=http://c.moreover.com/click/here.pl%3fz2511267656%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988618&HITNO=8&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988618&THISHREF=http://c.moreover.com/click/here.pl%3fz2511267656%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988015&HITNO=9&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988015&THISHREF=http://c.moreover.com/click/here.pl%3fz2510384843%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988015&HITNO=9&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988015&THISHREF=http://c.moreover.com/click/here.pl%3fz2510384843%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: One-day conference focuses on effective strategies for treating autismhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987279&HITNO=10&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987279&THISHREF=http://c.moreover.com/click/here.pl%3fz2509745787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987279&HITNO=10&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987279&THISHREF=http://c.moreover.com/click/here.pl%3fz2509745787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizureshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987149&HITNO=11&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987149&THISHREF=http://c.moreover.com/click/here.pl%3fz2509632690%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987149&HITNO=11&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987149&THISHREF=http://c.moreover.com/click/here.pl%3fz2509632690%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Journal of Tampa Bay: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizureshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987147&HITNO=12&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987147&THISHREF=http://c.moreover.com/click/here.pl%3fz2509632241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987147&HITNO=12&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987147&THISHREF=http://c.moreover.com/click/here.pl%3fz2509632241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Review Albany: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizureshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987146&HITNO=13&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987146&THISHREF=http://c.moreover.com/click/here.pl%3fz2509632176%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987146&HITNO=13&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987146&THISHREF=http://c.moreover.com/click/here.pl%3fz2509632176%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSacramento Business Journal: FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987098&HITNO=14&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987098&THISHREF=http://c.moreover.com/click/here.pl%3fz2509594292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987098&HITNO=14&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAL&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987098&THISHREF=http://c.moreover.com/click/here.pl%3fz2509594292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: